medicare and glp 1 drugs is about to cover GLP-1 for weight loss. Here's what to know Medicare and GLP-1s: What's covered,

Most patients begin to see a reduction in hair fall within the first few sessions, with visible improvements in density and hair quality appearing between three to six months

Kubota S, Okada M, Yoshimoto M, Murata N, Yamasaki Z, Wada T, Imahori K, Ohsawa N, Takaku F

By age 60, this drops to approximately 80 ng/mL, a reduction of 60% that correlates with visible signs of aging including hair thinning

This depletion can lead to anemia, and also an increased risk that their breastfed infants become vitamin deficient

The observed weight loss might not be as high as with some of the newer injectable GLP-1 medications, he says, but the oral pills offer the potential of having an inexpensive, accessible drug. Both pills must be taken daily, whereas many GLP-1 injections are weekly

Safety: what we know, what we dont What clinical trial safety reviews suggest The clinical safety review literature reports several reassuring signals: No meaningful increase in IGF-1 in monitored long-term studies (jofem.org) No clear negative effect on carbohydrate metabolism in testing described (contrast with full hGH) (jofem.org) No clear immunogenicity signal (e.g., anti-AOD antibodies) in the subset assessed in those trials (jofem.org) The major limitation: long-term real-world certainty is thin The problem with many peptides is not that everything is dangerousits that the certainty level is often lower than patients assume